Compounds > tac 278
Page last updated: 2024-09-04

tac 278 and Breast Neoplasms

tac 278 has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for tac 278 and Breast Neoplasms

ArticleYear
[Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:10

    Topics: Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms

1982